Rockefeller Capital Management’s Psyence Biomedical PBM Stock Holding History
Bought
Maintained
Sold
Other funds holding PBM
Rockefeller Capital Management's PBM Position: Q3 2026 in Review
Rockefeller Capital Management opened a new position in Psyence Biomedical (PBM) in Q3 2026: 235 shares worth $1.28K. The stake represents ﹤0.01% of the portfolio and ranks #4620 among its holdings.
10 funds tracked by Wall St. Rank hold PBM as of Q3 2026.
- Rockefeller Capital Management held 235 shares of Psyence Biomedical worth $1.28K as of Q3 2026.
- Psyence Biomedical was a new Rockefeller Capital Management position in Q3 2026.
- Psyence Biomedical made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4620 holding.
- 10 funds tracked by Wall St. Rank held Psyence Biomedical as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.